DCT

3:18-cv-11219

Amgen Inc v. Aurobindo Pharma Ltd

General

Filed

06/28/18

Cause of ActionPatent Infringement

SectorBiotech

Status

Closed (04/06/21)

Patent Owner

Operating Company (W)

PACER3:18-cv-11219

CourtD. New Jersey

Judge	Period	PO Win Rate
Michael A. Shipp	--	70%

Plaintiff

Party

Name	Ratings
Amgen USA Inc	L4B
Celgene Corp	L4A

Attorney

Name	Ratings
Jones Day	L5A
Sarah Geers	L3C
Covington & Burling LLP	L4B
George F. Pappas	L5A
Christopher N. Sipes	L5C
Michael N. Kennedy	L5C
Alexa Hansen	L4A
Saul Ewing LLP	L3B
William C. Baton	L5A
Charles M. Lizza	L5A
Sarah Ann Sullivan	L4A
David L. Moses	L3A
GibbonsLocal	L3B
Charles H. Chevalier	L3D
Christine A. Gaddis	L1C
Amgen Inc	L2C
Wendy A. Whiteford	L5A
C. Nichole Gifford	L5E
Dennis J. Smith	L4B
Gregory D. Bonifield	L4C
Eric Agovino	L4C

Defendant

Party

Name	Ratings
Aurobindo Pharma USA Inc	L4E

Attorney

Name	Ratings
Fisherbroyles LLP	L1E
Joseph Schramm, III	L4D
Karin K. Sage	L3B
Irene Oria	L3C
Gurpreet S. Walia	L3D
Attorney at LawLocal	---- --
Aurobindo P. U. S. A. Inc	---- --
Aurobindo P. Limited	---- --